X-155061857-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001018024.3(CMC4):āc.193T>Cā(p.Ser65Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000166 in 1,206,573 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001018024.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMC4 | NM_001018024.3 | c.193T>C | p.Ser65Pro | missense_variant | 3/3 | ENST00000369484.8 | NP_001018024.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMC4 | ENST00000369484.8 | c.193T>C | p.Ser65Pro | missense_variant | 3/3 | 1 | NM_001018024.3 | ENSP00000358496.3 | ||
ENSG00000288258 | ENST00000504061.1 | n.*207T>C | non_coding_transcript_exon_variant | 3/3 | 3 | ENSP00000427132.1 | ||||
ENSG00000288258 | ENST00000504061.1 | n.*207T>C | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000427132.1 | ||||
CMC4 | ENST00000369479.1 | c.193T>C | p.Ser65Pro | missense_variant | 3/3 | 3 | ENSP00000358491.1 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112364Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34512
GnomAD4 exome AF: 9.14e-7 AC: 1AN: 1094209Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 359781
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112364Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2022 | The c.193T>C (p.S65P) alteration is located in exon 3 (coding exon 2) of the CMC4 gene. This alteration results from a T to C substitution at nucleotide position 193, causing the serine (S) at amino acid position 65 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at